HER family protein expression and activation predicts response to combination T-DM1/pertuzumab in HER2+patients in the I-SPY 2 TRIAL.-MedSci.cn

HER family protein expression and activation predicts response to combination T-DM1/pertuzumab in HER2+patients in the I-SPY 2 TRIAL.

Wulfkuhle, JD; Wolf, DM; Yau, C; Gallagher, RI; Swigart, LB; Hirst, GL; Yee, D; Pohlmann, PR; Elias, AD; Moulder, SL; Tripathy, D; DeMichele, A; Esserman, L; Berry, DA; Van't Veer, L; Petricoin, E

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):

科室
- - 订阅+
  - 更多科室
工具
服务